Home > > > > Report Detail

Cystic Fibrosis Therapeutics - Global Market Insights and Sales Trends 2024

Publisher Name :
Date: 25-Dec-2023
No. of pages: 113
Inquire Before Buying

The global Cystic Fibrosis Therapeutics market size is expected to reach US$ 12680 million by 2029, growing at a CAGR of 13.5% from 2023 to 2029. The market is mainly driven by the significant applications of Cystic Fibrosis Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Cystic Fibrosis Therapeutics market. CFTR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mucolytics segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Cystic Fibrosis Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Cystic Fibrosis Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Cystic Fibrosis Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cystic Fibrosis Therapeutics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Cystic Fibrosis Therapeutics covered in this report include Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, AstraZeneca, Bayer, Celtaxsys and Pharmaxis, etc.

The global Cystic Fibrosis Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

- Vertex Pharmaceuticals

- F. Hoffmann-La Roche

- AbbVie

- Gilead Sciences

- Novartis

- AstraZeneca

- Bayer

- Celtaxsys

- Pharmaxis

- ProQR Therapeutics

- PTC Therapeutics

- Alcresta Therapeutics

- Insmed Incorporated

- Savara

- Cyclacel Pharmaceuticals

- Vectura

- Allergan

Global Cystic Fibrosis Therapeutics market, By Region:

- North America (U.S., Canada, Mexico)

- Europe (Germany, France, UK, Italy, etc.)

- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

- South America (Brazil, etc.)

- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Cystic Fibrosis Therapeutics market, Segment by Type:

- CFTR

- Mucolytics

- PERT

- Anti-infectives

- Bronchodilators

Global Cystic Fibrosis Therapeutics market, by Application

- Hospitals

- Clinics

Core Chapters

Chapter One: Introduces the Report Scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Four: Detailed analysis of Cystic Fibrosis Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Research Finding/Conclusion

Cystic Fibrosis Therapeutics - Global Market Insights and Sales Trends 2024

Table of Contents
1 Market Overview of Cystic Fibrosis Therapeutics
1.1 Cystic Fibrosis Therapeutics Market Overview
1.1.1 Cystic Fibrosis Therapeutics Product Scope
1.1.2 Cystic Fibrosis Therapeutics Market Status and Outlook
1.2 Global Cystic Fibrosis Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cystic Fibrosis Therapeutics Market Size by Region (2018-2029)
1.4 Global Cystic Fibrosis Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Cystic Fibrosis Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cystic Fibrosis Therapeutics Market Size (2018-2029)
1.6.1 North America Cystic Fibrosis Therapeutics Market Size (2018-2029)
1.6.2 Europe Cystic Fibrosis Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Cystic Fibrosis Therapeutics Market Size (2018-2029)
1.6.4 Latin America Cystic Fibrosis Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Cystic Fibrosis Therapeutics Market Size (2018-2029)
2 Cystic Fibrosis Therapeutics Market by Type
2.1 Introduction
2.1.1 CFTR
2.1.2 Mucolytics
2.1.3 PERT
2.1.4 Anti-infectives
2.1.5 Bronchodilators
2.2 Global Cystic Fibrosis Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cystic Fibrosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cystic Fibrosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cystic Fibrosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cystic Fibrosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cystic Fibrosis Therapeutics Revenue Breakdown by Type (2018-2029)
3 Cystic Fibrosis Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global Cystic Fibrosis Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cystic Fibrosis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cystic Fibrosis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cystic Fibrosis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cystic Fibrosis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cystic Fibrosis Therapeutics Revenue Breakdown by Application (2018-2029)
4 Cystic Fibrosis Therapeutics Competition Analysis by Players
4.1 Global Cystic Fibrosis Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2022)
4.3 Date of Key Players Enter into Cystic Fibrosis Therapeutics Market
4.4 Global Top Players Cystic Fibrosis Therapeutics Headquarters and Area Served
4.5 Key Players Cystic Fibrosis Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Cystic Fibrosis Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Vertex Pharmaceuticals
5.1.1 Vertex Pharmaceuticals Profile
5.1.2 Vertex Pharmaceuticals Main Business
5.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Products, Services and Solutions
5.1.4 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Vertex Pharmaceuticals Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 AbbVie
5.3.1 AbbVie Profile
5.3.2 AbbVie Main Business
5.3.3 AbbVie Cystic Fibrosis Therapeutics Products, Services and Solutions
5.3.4 AbbVie Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Gilead Sciences Recent Developments
5.4 Gilead Sciences
5.4.1 Gilead Sciences Profile
5.4.2 Gilead Sciences Main Business
5.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Products, Services and Solutions
5.4.4 Gilead Sciences Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Gilead Sciences Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Cystic Fibrosis Therapeutics Products, Services and Solutions
5.5.4 Novartis Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Cystic Fibrosis Therapeutics Products, Services and Solutions
5.6.4 AstraZeneca Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 AstraZeneca Recent Developments
5.7 Bayer
5.7.1 Bayer Profile
5.7.2 Bayer Main Business
5.7.3 Bayer Cystic Fibrosis Therapeutics Products, Services and Solutions
5.7.4 Bayer Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Bayer Recent Developments
5.8 Celtaxsys
5.8.1 Celtaxsys Profile
5.8.2 Celtaxsys Main Business
5.8.3 Celtaxsys Cystic Fibrosis Therapeutics Products, Services and Solutions
5.8.4 Celtaxsys Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Celtaxsys Recent Developments
5.9 Pharmaxis
5.9.1 Pharmaxis Profile
5.9.2 Pharmaxis Main Business
5.9.3 Pharmaxis Cystic Fibrosis Therapeutics Products, Services and Solutions
5.9.4 Pharmaxis Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Pharmaxis Recent Developments
5.10 ProQR Therapeutics
5.10.1 ProQR Therapeutics Profile
5.10.2 ProQR Therapeutics Main Business
5.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
5.10.4 ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 ProQR Therapeutics Recent Developments
5.11 PTC Therapeutics
5.11.1 PTC Therapeutics Profile
5.11.2 PTC Therapeutics Main Business
5.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
5.11.4 PTC Therapeutics Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 PTC Therapeutics Recent Developments
5.12 Alcresta Therapeutics
5.12.1 Alcresta Therapeutics Profile
5.12.2 Alcresta Therapeutics Main Business
5.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
5.12.4 Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Alcresta Therapeutics Recent Developments
5.13 Insmed Incorporated
5.13.1 Insmed Incorporated Profile
5.13.2 Insmed Incorporated Main Business
5.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Products, Services and Solutions
5.13.4 Insmed Incorporated Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Insmed Incorporated Recent Developments
5.14 Savara
5.14.1 Savara Profile
5.14.2 Savara Main Business
5.14.3 Savara Cystic Fibrosis Therapeutics Products, Services and Solutions
5.14.4 Savara Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 Savara Recent Developments
5.15 Cyclacel Pharmaceuticals
5.15.1 Cyclacel Pharmaceuticals Profile
5.15.2 Cyclacel Pharmaceuticals Main Business
5.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Products, Services and Solutions
5.15.4 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 Cyclacel Pharmaceuticals Recent Developments
5.16 Vectura
5.16.1 Vectura Profile
5.16.2 Vectura Main Business
5.16.3 Vectura Cystic Fibrosis Therapeutics Products, Services and Solutions
5.16.4 Vectura Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.16.5 Vectura Recent Developments
5.17 Allergan
5.17.1 Allergan Profile
5.17.2 Allergan Main Business
5.17.3 Allergan Cystic Fibrosis Therapeutics Products, Services and Solutions
5.17.4 Allergan Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.17.5 Allergan Recent Developments
6 North America
6.1 North America Cystic Fibrosis Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cystic Fibrosis Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cystic Fibrosis Therapeutics Market Dynamics
11.1 Cystic Fibrosis Therapeutics Industry Trends
11.2 Cystic Fibrosis Therapeutics Market Drivers
11.3 Cystic Fibrosis Therapeutics Market Challenges
11.4 Cystic Fibrosis Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
Table 1. Global Market Cystic Fibrosis Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Cystic Fibrosis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Cystic Fibrosis Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Cystic Fibrosis Therapeutics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Cystic Fibrosis Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Cystic Fibrosis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2024-2029)
Table 11. North America Cystic Fibrosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Cystic Fibrosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Cystic Fibrosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Cystic Fibrosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Cystic Fibrosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Cystic Fibrosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Cystic Fibrosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Cystic Fibrosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Cystic Fibrosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Cystic Fibrosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Cystic Fibrosis Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Cystic Fibrosis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2024-2029)
Table 26. North America Cystic Fibrosis Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Cystic Fibrosis Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Cystic Fibrosis Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Cystic Fibrosis Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Cystic Fibrosis Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Cystic Fibrosis Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Cystic Fibrosis Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Cystic Fibrosis Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Cystic Fibrosis Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Cystic Fibrosis Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Cystic Fibrosis Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Cystic Fibrosis Therapeutics Market
Table 40. Global Cystic Fibrosis Therapeutics Key Players Headquarters and Area Served
Table 41. Cystic Fibrosis Therapeutics Product Solution and Service
Table 42. Global Cystic Fibrosis Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Vertex Pharmaceuticals Basic Information List
Table 45. Vertex Pharmaceuticals Description and Business Overview
Table 46. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Vertex Pharmaceuticals (2018-2023)
Table 48. Vertex Pharmaceuticals Recent Developments
Table 49. F. Hoffmann-La Roche Basic Information List
Table 50. F. Hoffmann-La Roche Description and Business Overview
Table 51. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of F. Hoffmann-La Roche (2018-2023)
Table 53. F. Hoffmann-La Roche Recent Developments
Table 54. AbbVie Basic Information List
Table 55. AbbVie Description and Business Overview
Table 56. AbbVie Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of AbbVie (2018-2023)
Table 58. AbbVie Recent Developments
Table 59. Gilead Sciences Basic Information List
Table 60. Gilead Sciences Description and Business Overview
Table 61. Gilead Sciences Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Gilead Sciences (2018-2023)
Table 63. Gilead Sciences Recent Developments
Table 64. Novartis Basic Information List
Table 65. Novartis Description and Business Overview
Table 66. Novartis Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Novartis (2018-2023)
Table 68. Novartis Recent Developments
Table 69. AstraZeneca Basic Information List
Table 70. AstraZeneca Description and Business Overview
Table 71. AstraZeneca Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of AstraZeneca (2018-2023)
Table 73. AstraZeneca Recent Developments
Table 74. Bayer Basic Information List
Table 75. Bayer Description and Business Overview
Table 76. Bayer Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Bayer (2018-2023)
Table 78. Bayer Recent Developments
Table 79. Celtaxsys Basic Information List
Table 80. Celtaxsys Description and Business Overview
Table 81. Celtaxsys Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Celtaxsys (2018-2023)
Table 83. Celtaxsys Recent Developments
Table 84. Pharmaxis Basic Information List
Table 85. Pharmaxis Description and Business Overview
Table 86. Pharmaxis Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Pharmaxis (2018-2023)
Table 88. Pharmaxis Recent Developments
Table 89. ProQR Therapeutics Basic Information List
Table 90. ProQR Therapeutics Description and Business Overview
Table 91. ProQR Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of ProQR Therapeutics (2018-2023)
Table 93. ProQR Therapeutics Recent Developments
Table 94. PTC Therapeutics Basic Information List
Table 95. PTC Therapeutics Description and Business Overview
Table 96. PTC Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 97. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of PTC Therapeutics (2018-2023)
Table 98. PTC Therapeutics Recent Developments
Table 99. Alcresta Therapeutics Basic Information List
Table 100. Alcresta Therapeutics Description and Business Overview
Table 101. Alcresta Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 102. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Alcresta Therapeutics (2018-2023)
Table 103. Alcresta Therapeutics Recent Developments
Table 104. Insmed Incorporated Basic Information List
Table 105. Insmed Incorporated Description and Business Overview
Table 106. Insmed Incorporated Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 107. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Insmed Incorporated (2018-2023)
Table 108. Insmed Incorporated Recent Developments
Table 109. Savara Basic Information List
Table 110. Savara Description and Business Overview
Table 111. Savara Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 112. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Savara (2018-2023)
Table 113. Savara Recent Developments
Table 114. Cyclacel Pharmaceuticals Basic Information List
Table 115. Cyclacel Pharmaceuticals Description and Business Overview
Table 116. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 117. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Cyclacel Pharmaceuticals (2018-2023)
Table 118. Cyclacel Pharmaceuticals Recent Developments
Table 119. Vectura Basic Information List
Table 120. Vectura Description and Business Overview
Table 121. Vectura Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 122. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Vectura (2018-2023)
Table 123. Vectura Recent Developments
Table 124. Allergan Basic Information List
Table 125. Allergan Description and Business Overview
Table 126. Allergan Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 127. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Allergan (2018-2023)
Table 128. Allergan Recent Developments
Table 129. North America Cystic Fibrosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 130. North America Cystic Fibrosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 131. Europe Cystic Fibrosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 132. Europe Cystic Fibrosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 133. Asia-Pacific Cystic Fibrosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 134. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 135. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 136. Asia-Pacific Cystic Fibrosis Therapeutics Market Share by Region (2018-2023)
Table 137. Asia-Pacific Cystic Fibrosis Therapeutics Market Share by Region (2024-2029)
Table 138. Latin America Cystic Fibrosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 139. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 140. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 141. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 142. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 143. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 144. Cystic Fibrosis Therapeutics Market Trends
Table 145. Cystic Fibrosis Therapeutics Market Drivers
Table 146. Cystic Fibrosis Therapeutics Market Challenges
Table 147. Cystic Fibrosis Therapeutics Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystic Fibrosis Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Cystic Fibrosis Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Cystic Fibrosis Therapeutics Market Share by Regions: 2022 VS 2029
Figure 4. Global Cystic Fibrosis Therapeutics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Cystic Fibrosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Cystic Fibrosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Cystic Fibrosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Cystic Fibrosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of CFTR
Figure 11. Global CFTR Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Mucolytics
Figure 13. Global Mucolytics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of PERT
Figure 15. Global PERT Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Anti-infectives
Figure 17. Global Anti-infectives Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Bronchodilators
Figure 19. Global Bronchodilators Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Global Cystic Fibrosis Therapeutics Market Size Share by Type: 2022 & 2029
Figure 21. North America Cystic Fibrosis Therapeutics Revenue Market Share by Type (2018-2029)
Figure 22. Europe Cystic Fibrosis Therapeutics Revenue Market Share by Type (2018-2029)
Figure 23. Asia-Pacific Cystic Fibrosis Therapeutics Revenue Market Share by Type (2018-2029)
Figure 24. Latin America Cystic Fibrosis Therapeutics Revenue Market Share by Type (2018-2029)
Figure 25. Middle East and Africa Cystic Fibrosis Therapeutics Revenue Market Share by Type (2018-2029)
Figure 26. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Global Cystic Fibrosis Therapeutics Market Size Share by Application: 2022 & 2029
Figure 29. North America Cystic Fibrosis Therapeutics Revenue Market Share by Application (2018-2029)
Figure 30. Europe Cystic Fibrosis Therapeutics Revenue Market Share by Application (2018-2029)
Figure 31. Asia-Pacific Cystic Fibrosis Therapeutics Revenue Market Share by Application (2018-2029)
Figure 32. Latin America Cystic Fibrosis Therapeutics Revenue Market Share by Application (2018-2029)
Figure 33. Middle East and Africa Cystic Fibrosis Therapeutics Revenue Market Share by Application (2018-2029)
Figure 34. Cystic Fibrosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 35. Global Top 5 and Top 10 Players Cystic Fibrosis Therapeutics Market Share in 2022
Figure 36. North America Cystic Fibrosis Therapeutics Market Share by Country (2018-2029)
Figure 37. U.S. Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 38. Canada Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 39. Germany Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 40. France Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 41. U.K. Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 42. Italy Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 43. Russia Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 44. Nordic Countries Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 45. Asia-Pacific Cystic Fibrosis Therapeutics Market Share by Region (2018-2029)
Figure 46. China Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 47. Japan Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 48. South Korea Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 49. Southeast Asia Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 50. India Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 51. Australia Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 52. Latin America Cystic Fibrosis Therapeutics Market Share by Country (2018-2029)
Figure 53. Mexico Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 54. Brazil Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 55. Middle East & Africa Cystic Fibrosis Therapeutics Market Share by Country (2018-2029)
Figure 56. Turkey Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 58. UAE Cystic Fibrosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report
  • Global Thyroid Gland Disorders Treatment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted. The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......
  • Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......
  • Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period. The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......
  • Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period. The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......
  • Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......
  • Global Enzyme Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......
  • Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 84
    According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......
  • Global Hormone Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......
  • Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs